What question did this study set out to answer?

To outline the design principles, emerging capabilities, and translational bottlenecks of hybrid protein–nucleic acid conjugates in diagnostics and molecular medicine.

September 1, 2026Bioconjugate Chemistry

Design Considerations for Next-Generation Protein–Nucleic Acid Conjugates in Biorecognition and Therapy

View Full Paper

Ask AI

Bookmark

Authors

SESasha B. Ebrahimi DSDevleena Samanta

Discussion

Member takes

Overview

Perspective review demonstrates synergistic advantages of protein-nucleic acid conjugates in diagnostic and therapeutic platforms, highlighting strategies to overcome translational hurdles.

Key Points

To outline the design principles, emerging capabilities, and translational bottlenecks of hybrid protein–nucleic acid conjugates in diagnostics and molecular medicine.
Synthesized recent advances in chemical biology, biomaterials engineering, and molecular diagnostics.
Evaluated conjugate performance parameters in single-cell detection assays and complex physiological media.
Assessed therapeutic mechanisms spanning targeted gene silencing, immunomodulatory signaling, and functional biomaterial design.
Conjugate systems enable signal amplification that achieves ultralow detection limits and single-cell selectivity in complex biological environments.
Hybrid architectures facilitate tissue-selective gene regulation and targeted immunotherapeutic responses beyond the capacity of individual components.
Widespread clinical translation requires resolving technical limitations in scalable synthesis, in vivo stability, and targeted intracellular delivery.

Cite This Study

Ebrahimi et al. (2026) studied this question.

synapsesocial.com/papers/6aa2fc0fab449f4ca5c22802 https://doi.org/10.1021/acs.bioconjchem.6c00398

View Full Paper

Ask AI

Bookmark

September 1, 2026Bioconjugate Chemistry

Design Considerations for Next-Generation Protein–Nucleic Acid Conjugates in Biorecognition and Therapy

View Full Paper

Ask AI

Bookmark

Authors

SESasha B. Ebrahimi DSDevleena Samanta

Discussion

Member takes

Overview

Perspective review demonstrates synergistic advantages of protein-nucleic acid conjugates in diagnostic and therapeutic platforms, highlighting strategies to overcome translational hurdles.

Key Points

To outline the design principles, emerging capabilities, and translational bottlenecks of hybrid protein–nucleic acid conjugates in diagnostics and molecular medicine.
Synthesized recent advances in chemical biology, biomaterials engineering, and molecular diagnostics.
Evaluated conjugate performance parameters in single-cell detection assays and complex physiological media.
Assessed therapeutic mechanisms spanning targeted gene silencing, immunomodulatory signaling, and functional biomaterial design.
Conjugate systems enable signal amplification that achieves ultralow detection limits and single-cell selectivity in complex biological environments.
Hybrid architectures facilitate tissue-selective gene regulation and targeted immunotherapeutic responses beyond the capacity of individual components.
Widespread clinical translation requires resolving technical limitations in scalable synthesis, in vivo stability, and targeted intracellular delivery.

Cite This Study

Ebrahimi et al. (2026) studied this question.

synapsesocial.com/papers/6aa2fc0fab449f4ca5c22802 https://doi.org/10.1021/acs.bioconjchem.6c00398

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark